The potential health benefits of GLP-1 diabetes and weight loss meds keep piling up: New research shows they may also shield your kidneys from harm. In the largest study to date on the effects of the drugs on the kidneys, researchers found GLP-1s help the protect the organs in people with or without diabetes.

As use of GLP-1 weight loss drugs including Wegovy and Ozempic increases, brands are introducing new offerings.

About 20% of patients — as many as 1 in 5 — may not respond well to medications like Mounjaro and Wegovy, according to several obesity experts.

GLP-1 medications like Ozempic and Wegovy are shielding the kidneys from harm, even as they help ease diabetes and obesity Folks taking the meds have significantly lower odds for kidney failure The drugs also appear to have big heart health benefits TUESDAY,

Popular diabetes and obesity drugs also protect kidneys, study suggests - The combined reduction in the risk of kidney failure, worsening kidney function and death due to kidney disease was 19%, researchers found.